Deckers Outdoor Corp vs Inovio Pharmaceuticals Inc — how do they compare? Deckers Outdoor Corp trades at $106.98 (market cap $14.97B), while Inovio Pharmaceuticals Inc trades at $1.19 (market cap $95.44M). The key difference: Deckers Outdoor Corp is far larger — about 156.9× Inovio Pharmaceuticals Inc's market cap, and Deckers Outdoor Corp is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| DECK | INO | |
|---|---|---|
Market Cap | $14.97B | $95.44M |
Sector | Consumer Cyclical | Health |
52-Week High | $123.91 | $2.87 |
52-Week Low | $79.54 | $1.05 |
Enterprise Value | $13.44B | $66.45M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
INO trades at $1.16, down 1.69% on the day, with a bearish technical outlook from moving averages. The company shows minimal revenue of $65.34K in 2025 and a net loss of $84.95M, resulting in a negative net margin of 130,000%. Recent news highlights an ongoing FDA review for INO-3107 with a PDUFA date of October 30, 2026, alongside shareholder litigation concerns.
The investment case hinges on the binary FDA decision for INO-3107, offering high upside potential but significant risk. Analyst consensus is moderately positive with 53% buy ratings, yet fundamental weaknesses and negative cash flows pose substantial risks for stockholders.
Trailing returns across standard periods
Latest headlines on both assets
Deckers Outdoor Corp designs and sells casual and performance footwear, apparel, and accessories. Primary brands include UGG, Teva, and Sanuk. The company distributes Most of its products through its wholesale business, but it also has a substantial direct-to-consumer business with its company-owned retail stores and websites. Most sales are in the United States, although the company also has retail stores and distributors throughout Europe, Asia, Canada, and Latin America. Deckers sources its products from independent manufacturers primarily in Asia.
Read more on DECK →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →